Stock market newcomer Ottobock significantly increases sales and profit

$DE000BCK2223 (+0,56%)
@EpsEra (getquin Robotic Expert)

The prosthesis manufacturer Ottobock is more optimistic about the year as a whole than before. Adjusted consolidated profit rose by 81 percent.

Thanks to strong growth in the first nine months, the world's largest prosthesis manufacturer Ottobock is more optimistic about the year as a whole than before. Sales growth in the core business is expected to be in the upper half of the forecast range of 10 to 13 percent, the company announced on Thursday in its first quarterly report since the IPO on October 9.

The return on sales (adjusted EBITDA margin) in the core business is still expected to be in the range of 25 to 26 percent.

From January to September, turnover in the core business rose by just under 14 percent to 1.16 billion euros. The operating result (adjusted EBITDA) increased by 29% to 281 million euros. Adjusted net profit rose by 81% to 119 million euros.

The medical technology company cited new products, acquisitions and efficiency improvements, among other things, as business drivers. Ottobock has previously emphasized that its business is driven more by innovations than by wars and natural disasters.

The shares of the family-owned company from Duderstadt in Lower Saxony were floated on the stock exchange at an issue price of 66 euros. Billionaire Klaus-Michael Kühne is the second largest shareholder after the founding family around Chairman of the Board of Directors Hans-Georg Näder. Last year, Ottobock generated sales of 1.43 billion euros with 9300 employees worldwide and an adjusted operating result (EBITDA) of 321 million euros.

https://www.wiwo.de/unternehmen/industrie/ottobock-boersenneuling-steigert-umsatz-und-gewinn-deutlich/100174182.html

Elsa E.@EpsEra

2Settimana

The figures are really strong and probably few would have expected them to be like this. Ottobock is delivering a level that one would not necessarily have expected in the short period after the IPO. A jump in profits of 81 percent is really strong and shows how much momentum there currently is in the core business.

From a robotics perspective, it is particularly interesting to see where the technology is heading. Ottobock is working on prostheses that not only function mechanically, but also actively interact with the patient's nervous system. This form of neuro-robotics can change the entire rehabilitation and orthopaedics market in the long term and gives the company a technological edge that should not be underestimated.
Have you already invested or are you planning to do so?

•

Tenbagger2024@Tenbagger2024

@EpsEra
Musk recently said. The most difficult thing would be the gripping technique of the hand.
Otto Bock seems to have mastered it.
I'll have to take a closer look at the multiples.
Since many shares lost drastically after the IPO, I was a bit apprehensive about getting in.

Max@Divident_e

My dear. Thank you

••